Atg2A is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| ATG2A |
|---|
| Gene Symbol | ATG2A |
| Full Name | Autophagy Related 2A |
| Chromosomal Location | 11q13.2 |
| NCBI Gene ID | 23130 |
| UniProt ID | Q9BSB5 |
| Protein Type | Peripheral Membrane Protein |
| Molecular Weight | ~206 kDa |
ATG2A is a crucial autophagy protein involved in autophagosome formation and lipid metabolism. It functions as a tether that connects the expanding autophagosome membrane to the ER and facilitates the transfer of lipids from donor membranes. ATG2A is essential for bulk autophagy and selective degradation of protein aggregates and damaged organelles.
¶ Function and Mechanism
ATG2A operates at the interface between the autophagosome and the endoplasmic reticulum:
- Membrane tethering: ATG2A bridges the growing autophagosome (phagophore) with ER-derived membranes
- Lipid transfer: ATG2A functions as a lipid transfer protein (LTP), mediating phospholipid delivery from ER to autophagosomal membranes
- WIPI proteins: ATG2A interacts with WIPI1/2/3/4 (WD repeat domain phosphoinositide-interacting proteins) to localize to the autophagosomal membrane
Recent structural studies have revealed the molecular mechanism:
- WIPI4 (WDR45) binds to ATG2A and recruits it to the phagophore
- ATG2A binds to PI3P (phosphatidylinositol 3-phosphate) on autophagosomal membranes
- The ATG2A C-terminal domain interacts with the ER, facilitating lipid transfer
- This complex is essential for the expansion from the initial isolation membrane to a complete autophagosome
ATG2A participates in multiple selective autophagy pathways:
- Aggrephagy: Clearance of ubiquitin-positive protein aggregates
- Mitophagy: Degradation of damaged mitochondria
- Xenophagy: Elimination of intracellular pathogens
- Ribophagy: Selective degradation of ribosomes
- Amyloid metabolism: ATG2A-mediated autophagy contributes to Aβ clearance; dysfunction may lead to Aβ accumulation
- Tau clearance: ATG2A is involved in the autophagic degradation of phosphorylated tau
- ER stress: ATG2A dysfunction exacerbates ER stress in AD neurons
- Lipid metabolism: Altered lipid homeostasis in AD brains involves ATG2A dysregulation
- Mitophagy impairment: ATG2A deficiency leads to accumulation of dysfunctional mitochondria
- Alpha-synuclein: ATG2A-mediated autophagy is crucial for clearing α-synuclein aggregates
- LRRK2 connection: LRRK2 mutations affect ATG2A-dependent autophagic flux
- Dopaminergic vulnerability: ATG2A may be particularly important in dopaminergic neuron survival
- TDP-43 pathology: ATG2A-mediated selective autophagy is impaired in TDP-43 ALS
- Protein aggregate clearance: Loss of ATG2A function leads to accumulation of toxic protein aggregates
- Axonal transport: ATG2A deficiency affects autophagosome transport in motor neurons
- Huntington's Disease: ATG2A activity helps clear mutant huntingtin aggregates
- Frontotemporal Dementia: ATG2A dysfunction contributes to protein aggregation
- Lysosomal Storage Disorders: ATG2A compensates for lysosomal dysfunction in certain contexts
Targeting ATG2A represents a promising therapeutic strategy:
| Approach |
Mechanism |
Status |
| ATG2A overexpression |
Enhance autophagy flux to clear aggregates |
Preclinical |
| Small molecule activators |
Promote ATG2A recruitment to autophagosomes |
Research |
| Gene therapy |
Viral delivery of ATG2A to neurons |
Preclinical |
| Combination therapy |
ATG2A activation with mTOR inhibitors |
Research |
- Core complex: WIPI4 (WDR45), WIPI3 (WDR45B), ATG2B
- PI3K complex: Beclin-1, PIK3C3/VPS34
- Autophagy machinery: LC3, GABARAP, ATG5-ATG12
- ER proteins: VAP proteins (ER membrane contact sites)
The study of Atg2A has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Kumar et al., Structure of the ATG2A-WIPI4 lipid transfer complex (2021)
- Bozic et al., ATG2A and ATG2B in autophagosome formation (2020)
- Tang et al., ATG2A in neurodegenerative disease models (2021)
- Jiang et al., Selective autophagy and neurodegeneration (2022)
- Osuna et al., ER-phagy receptors in neurodegeneration (2022)